Invention Grant
- Patent Title: Imidazopyrazines as protein kinase inhibitors
- Patent Title (中): 咪唑吡嗪作为蛋白激酶抑制剂
-
Application No.: US11936380Application Date: 2007-11-07
-
Publication No.: US07511040B2Publication Date: 2009-03-31
- Inventor: David B. Belanger , M. Arshad Siddiqui , Timothy J. Guzi , Patrick J. Curran , Praveen K. Tadikonda , Blake Hamann , Panduranga Adulla P. Reddy , Lianyun Zhao
- Applicant: David B. Belanger , M. Arshad Siddiqui , Timothy J. Guzi , Patrick J. Curran , Praveen K. Tadikonda , Blake Hamann , Panduranga Adulla P. Reddy , Lianyun Zhao
- Applicant Address: US NJ Kenilworth
- Assignee: Schering Corporation
- Current Assignee: Schering Corporation
- Current Assignee Address: US NJ Kenilworth
- Agent Palaiyur S. Kalyanaraman
- Main IPC: C07D471/02
- IPC: C07D471/02
Abstract:
In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or Aurora kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or Aurora kinases using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:
Public/Granted literature
- US20080139571A1 IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS Public/Granted day:2008-06-12
Information query
